Skip to main content
. 2021 Oct 6;37(10):1982–1992. doi: 10.1093/ndt/gfab290

Table 2.

Summary of treatment effects, treatment-related adverse events, the rank by P-score and the level of confidence from 14 interventions

RLS severity Sleep quality Adverse events
P-score P-score P-scores Confidence
Intervention MD (95% CI) (%) Rank SMD (95% CI) (%) Rank OR (95% CI) (%) Rank of evidenceb
Cool dialysate 16.82 (10.63–23.02) 97.24 1 2.25 (0.14–35.58) 41.30 9 High
ISE 12.00 (7.04–16.97) 81.46 2 −0.10 (−0.84–0.64) 0.1418 4a 1.27 (0.18–8.72) 28.98 12 Low
Aromatherapy massage 10.91 (6.96–14.85) 76.22 3 0.71 (0.10–5.10) 67.57 1 Low
Gabapentin 8.90 (1.95–15.85) 63.06 4 2.00 (0.47–3.53) 0.9426 1 4.00 (0.29–54.52) 28.98 13 Very low
Reflexology 8.05 (2.73–13.37) 56.37 5 1.07 (0.08–15.04) 57.26 7 Very low
Vitamin C 7.73 (2.14–13.32) 54.62 6 1.66 (0.15–18.03) 49.59 8 Moderate
Vitamin C + vitamin E 7.61 (0.05–15.17) 53.82 7 5.35 (0.41–69.49) 22.59 14 Low
Vitamin E 7.41 (−0.28–15.10) 52.50 8 3.54 (0.25–49.78) 32.07 11 Moderate
Dopamine agonist 7.14 (2.01–12.27) 49.86 9 0.52 (−0.80–1.85) 0.4400 3 2.78 (0.44–17.73) 35.14 10 Very low
Iron 6.57 (−1.00–14.14) 47.43 10 0.69 (0.04–11.70) 65.74 2 Very low
IAE + dopamine agonist 5.13 (−9.91–20.16) 42.66 11 0.92 (0.01–117.00) 57.32 6 Low
IAE 3.83 (−4.87–12.53) 32.93 12 −0.10 (−0.84–0.64) 0.1418 4a 0,92 (0.06–13.22) 60.73 3 Very low
Acupoint therapy 1.61 (−3.67–6.88) 18.83 13 1.34 (0.62–2.06) 0.7684 2 1.00 (0.06–16.26) 58.38 4 Low
NES −0.97 (−12.42–10.47) 12.99 14 0.92 (0.01–107.97) 57.41 5 Very low
a

Intradialytic stretching exercise and intradialytic aerobic exercise were merged as one group when analysing sleep quality.

P-scores (as percentages) and rank for each intervention were obtained from standard network meta-analysis.

bConfidence of evidence was assessed according to the results of NMA regarding RLS severity treatment effect by CINeMA.

IAE, intradialytic aerobic exercise; ISE, intradialytic stretching exercise; NES, neuromuscular electrical stimulation.